I will, Mr. Chair.
What I can tell you is the overall breakdown for vaccines as is in the FES from last November. The total envelope is $14.3 billion: $13 billion of that is for medical research and vaccines; $1.2 billion is for another envelope of medical research; and $126 million is for biomanufacturing.
What I can say today is that the government announced $1 billion to secure access to vaccines up front, but there is an overall envelope, as you have noticed, for vaccines, vaccine supplies and medical research. That's the breakdown that I'm able to talk to you about today.